Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide
Sponsor: Janssen-Cilag Ltd.
Summary
The purpose of this study is to assess the real-world outcomes differences between apalutamide or enzalutamide plus androgen deprivation therapy (ADT) for the treatment of participants with metastatic hormone-sensitive prostate cancer (mHSPC).
Official title: Prospective, Multi-Country, Observational Study of Clinical Outcomes for Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With ADT Plus Apalutamide or Enzalutamide Under Routine Clinical Practice (ArtemisPRO)
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
504
Start Date
2023-07-05
Completion Date
2026-06-05
Last Updated
2026-03-13
Healthy Volunteers
No
Interventions
Apalutamide
No interventions will be administered as a part of this study. Participants will receive apalutamide as per their routine clinical practice.
Enzalutamide
No interventions will be administered as a part of this study. Participants will receive enzalutamide as per their routine clinical practice.
Locations (53)
Akh Wien
Vienna, Austria
Klinikum Wels Grieskirchen
Wels, Austria
Institut Sainte Catherine
Avignon, France
Institut Bergonie
Bordeaux, France
Polyclinique Bordeaux Nord Acquitaine
Bordeaux, France
Clinique Pasteur- Lanroze
Brest, France
Hopital Michallon CHU Grenoble Alpes
La Tronche, France
Hôpital Edouard Herriot
Lyon, France
Centre d'oncologie de Gentilly
Nancy, France
CHU Nimes
Nîmes, France
Hopital Europeen Georges-Pompidou
Paris, France
Hopital Tenon
Paris, France
Centre Hospitalier Rene Dubos Pontoise
Pontoise, France
Clinique de la Croix du Sud
Quint-Fonsegrives, France
Centre Hospitalier Prive
Saint-Grégoire, France
Clinique Sainte Anne
Strasbourg, France
Hopital Foch
Suresnes, France
CHU de Toulouse
Toulouse, France
Urologie Dierdorf
Dierdorf, Germany
St. Elisabeth Hospital Leipzig
Dresden, Germany
Urologicum Duisburg
Duisburg, Germany
Urologisches Zentrum Mittelhessen
Gladenbach, Germany
Praxis Dr. Serkan Filiz
Hamburg, Germany
Universitatsmedizin der Johannes Gutenberg Universitat Mainz
Mainz, Germany
Universitaetsklinikum Muenster
Münster, Germany
Krankenhaus Barmherzige Brüder Regensburg
Regensburg, Germany
Alexandra General Hospital of Athens
Athens, Greece
Anticancer Oncology Hospital of Athens Agios Savvas
Athens, Greece
Attikon University General Hospital of Attica
Athens, Greece
General Oncology Hospital of Kifisias "Agioi Anargyroi
Athens, Greece
University Hospital of Heraklion
Heraklion, Greece
University General Hospital of Rio Patras
Pátrai, Greece
Papageorgiou General Hospital Of Thessaloniki
Thessaloniki, Greece
Hosp Univ A Coruna
A Coruña, Spain
Hosp. Torrecardenas
Almería, Spain
Hosp. Puerta Del Mar
Cadiz, Spain
Hosp. Gral. Univ. de Castellon
Castellon, Spain
Hosp. Univ. Lucus Augusti
Lugo, Spain
Hosp Regional Univ de Malaga
Málaga, Spain
Hosp. Univ. de Canarias
San Cristóbal de La Laguna, Spain
Hosp. Clinico Univ. de Santiago
Santiago de Compostela, Spain
Hosp. Univ. I Politecni La Fe
Valencia, Spain
Frimley Health NHS Foundation Trust
Berkshire, United Kingdom
Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital
Cornwall, United Kingdom
Torbay Hospital-Devon
Devon, United Kingdom
Dorset County Hospital Nhs Foundation Trust
Dorchester, United Kingdom
Royal Surrey County Hospital NHS Trust
Guildford, United Kingdom
University College London Hospitals Nhs Foundation Trust
London, United Kingdom
Royal Free London NHS Foundation Trust
London, United Kingdom
Pennine Care Nhs Foundation Trust
Oldham, United Kingdom
Scunthorpe General Hospital
Scunthorpe, United Kingdom
Taunton and Somerset NHS Foundation Trust
Taunton, United Kingdom
University Hospitals Sussex NHS Foundation Trust Worthing Hospital
Worthing, United Kingdom